-The Times of India NEW DELHI: The government has invoked special powers under the law to prohibit stent makers from withdrawing their products from the market for the next six months. Amid reports that several manufacturers, including Abbott and Medtronic, are seeking to withdraw premium, high-priced stents from the Indian market on account of the price cap imposed by National Pharmaceutical Pricing Authority (NPPA), the government has directed companies to maintain production,...
More »SEARCH RESULT
Total Matching Records found : 326
Govt's generic push will dent Rs 90,000-cr branded pharma market -Veena Mani & Aneesh Phadnis
-Business Standard To make medicines cheaper, in another measure, govt added 200 drug formulations to NLEM list New Delhi/ Mumbai: Pharma companies may soon start wooing chemists as the Narendra Modi government plans to make it mandatory for doctors to prescribe pure-generic drugs, instead of branded generics as they do now. Though the plan was first announced in this year’s Budget, the prime minister spoke about it for the first time at a...
More »Generic prescription hurdles
-The Telegraph New Delhi: Regulatory efforts to get doctors in India to prescribe medicines only through their generic names, initiated about 15 years ago, will need to overcome legal challenges and resistance from sections of doctors and the pharmaceutical industry, experts said. Senior pharmacologists and industry analysts have also said it will be misleading to presume that prescriptions with generic names will automatically translate into lower medicine bills for patients as studies...
More »Cheap generic vs costly branded: Issues in picking right drug in India -Kaunain Sheriff M
-The Indian Express Prime Minister Narendra Modi wants doctors to prescribe generic medicines over branded ones. KAUNAIN SHERIFF M answers key questions on the pricing of drugs and beyond. * What exactly has Prime Minister Narendra Modi said on generic drugs? Speaking in Surat on April 17, the Prime Minister referred to the Pradhan Mantri Bharatiya Janaushadhi Pariyojana (PMBJP), which aims to provide cheaper medical drugs to the people. “In the coming days,...
More »NPPA puts price cap on cardiac stents; says hospitals overcharge -Kundan Pandey
-Down to Earth The average cost of drug eluting stent for domestic companies is around Rs 8,000 but it is sold to patients for Rs 24,000 to Rs 1.5 lakh In a decision that will benefit thousands of people in the country, the National Pharmaceutical Pricing Authority (NPPA) has finally put a ceiling on prices of cardiac stent—a small mesh tube that's used to treat narrow or weak arteries. Cardiac stents...
More »
